Laura Tomitz

Laura Tomitz serves as a key procurement lead within the W4PZ USA Medical Research Acquisition Act, operating under the Department of the Army’s Medical Research and Development Command. She manages the acquisition lifecycle for high-priority biomedical research and technical development contracts aimed at enhancing warfighter health and operational readiness. Her portfolio focuses on translating laboratory innovations into field-deployable medical solutions, overseeing solicitations for advanced diagnostics, therapeutic platforms, and analytical tools in life sciences. Tomitz plays a critical role in aligning contracting strategies with the agency’s mission to accelerate the transition of cutting-edge research from concept to combat support. Tomitz collaborates with a diverse ecosystem of research institutions, biotechnology firms, and engineering contractors, primarily engaging with organizations possessing expertise in clinical translation, molecular diagnostics, and biomedical instrumentation. While no single contractor dominates her portfolio, she consistently partners with entities capable of rapid prototyping, regulatory compliance, and scalable production of medical technologies. Her working relationships emphasize technical rigor, agility, and mission alignment over volume-based vendor loyalty, fostering long-term collaboration with firms that demonstrate proven capability in defense-relevant biomedical innovation. Tomitz’s contracting activity is entirely non-set-aside, with 100% of awards issued under full and open competition. This reflects a strategic prioritization of technical excellence and mission-critical capability over socioeconomic preferences, though small businesses remain eligible and competitive within the open market. Her approach underscores a commitment to selecting the most qualified offerors regardless of size or certification, ensuring that warfighter needs are met with the highest standards of innovation and performance. Her primary procurement focus lies in NAICS 541714 and 541715, encompassing biotechnology R&D and broader life sciences research, alongside NAICS 238210 for specialized medical facility electrical systems supporting advanced lab environments. She routinely procures next-generation biosensors, point-of-care diagnostic devices, bioinformatics platforms, and integrated clinical research infrastructure—reflecting deep domain expertise in military-relevant biomedical engineering and translational science.